$5.58
Boston-based research device developer 908 Devices completed its $125 million initial public offering, and its shares are now available to trade on the Nasdaq under the ticker "MASS." Shares are available for limit orders via Robinhood.
Our top picks for where to buy 908 Devices stock
How to buy 908 Devices stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – MASS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy 908 Devices stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
908 Devices stock price (NASDAQ: MASS)
Use our graph to track the performance of MASS stocks over time.908 Devices shares at a glance
Latest market close | $5.54 |
---|---|
52-week range | $4.57 - $12.51 |
50-day moving average | $5.83 |
200-day moving average | $6.71 |
Wall St. target price | $15.33 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.07 |
Is it a good time to buy 908 Devices stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
908 Devices price performance over time
Historical closes compared with the close of $5.54 from 2024-07-22
1 week (2024-07-17) | -8.88% |
---|---|
1 month (2024-06-24) | 5.93% |
3 months (2024-04-24) | -1.42% |
6 months (2024-01-24) | -28.61% |
1 year (2023-07-24) | -26.62% |
---|---|
2 years (2022-07-22) | -73.69% |
3 years (2021-07-23) | 32.58 |
5 years (2019-07-20) | N/A |
908 Devices financials
Revenue TTM | $50.7 million |
---|---|
Gross profit TTM | $26 million |
Return on assets TTM | -12.9% |
Return on equity TTM | -20.61% |
Profit margin | -68.56% |
Book value | $4.77 |
Market Capitalization | $182.4 million |
TTM: trailing 12 months
908 Devices share dividends
We're not expecting 908 Devices to pay a dividend over the next 12 months.
You may also wish to consider:
- ResMed (RMD.US) (0.94% forward annual dividend yield)
- Novartis AG ADR (NVS.US) (3.38% forward annual dividend yield)
908 Devices share price volatility
Over the last 12 months, 908 Devices's shares have ranged in value from as little as $4.57 up to $12.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 908 Devices's is 1.012. This would suggest that 908 Devices's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put 908 Devices's beta into context you can compare it against those of similar companies.
- Quidel Corporation (QDEL.US): 0.067
- ResMed (RMD.US): 0.664
- Novartis AG ADR (NVS.US): 0.491
908 Devices overview
908 Devices Inc. , a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Frequently asked questions
nullWhat percentage of 908 Devices is owned by insiders or institutions?
Currently 7.654% of 908 Devices shares are held by insiders and 78.541% by institutions. How many people work for 908 Devices?
Latest data suggests 230 work at 908 Devices. When does the fiscal year end for 908 Devices?
908 Devices's fiscal year ends in December. Where is 908 Devices based?
908 Devices's address is: 645 Summer Street, Boston, MA, United States, 02210 What is 908 Devices's ISIN number?
908 Devices's international securities identification number is: US65443P1021
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question